Avishkaran-Foundation for Pharma Innovation
About Avishkaran-Foundation for Pharma Innovation
Data last updated:
Avishkaran-Foundation for Pharma Innovation is a private not for profit company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 03 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85300TG2021NPL149258. Its GSTIN is 36AAUCA8876B1Z5 (Telangana).
It is led by directors including Nanduri Srinivas and Gananadhamu Samanthula.
Its last annual general meeting (AGM) was held on 19 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Niper Opp. Rai Business School Beside Idpl Balanagar Hyderabad, Telangana, India – 500037.
As per the financials filed for FY 2025, the company reported a revenue of ₹56.83 Lakh, a decline of 15% compared to the previous year. For the same year it recorded a net loss of ₹8.26 Lakh (net margin -14.5%) and EBITDA of ₹18.65 Lakh (EBITDA margin 32.8%). Revenue has grown at a compounded annual rate (CAGR) of 56% over three years.
Company details
Contact details
Avishkaran-Foundation for Pharma Innovation's registered office is in Hyderabad, Telangana.
- Registered AddressNiper Opp. Rai Business School Beside Idpl Balanagar Hyderabad, Telangana, India – 500037
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Avishkaran-Foundation for Pharma Innovation
FY 2025 filings availableAvishkaran-Foundation for Pharma Innovation reported revenue of ₹56.83 Lakh (down 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 15% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 56%. EBITDA fell 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹18.65 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8.26 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 32.8% | ||||
| Net Profit Margin | -14.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Avishkaran-Foundation for Pharma Innovation, buy the company report.
Board of directors of Avishkaran-Foundation for Pharma Innovation
Avishkaran-Foundation for Pharma Innovation has 7 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nanduri Srinivas | Director | 03 Mar 2021 | 5 Years 8 Months | Current |
| Gananadhamu Samanthula | Director | 03 Mar 2021 | 5 Years 8 Months | Current |
| Padmaja Surapureddy | Director | 14 Dec 2023 | 2 Years 10 Months | Current |
| Anil Wali | Director | 14 Dec 2023 | 2 Years 10 Months | Current |
| Ramjee Pallela | Director | 14 Dec 2023 | 2 Years 10 Months | Current |
| Saurabh Srivastava | Director | 14 Dec 2023 | 2 Years 10 Months | Current |
Peer comparison
Avishkaran-Foundation for Pharma Innovation is compared with the 10 companies closest to it by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vatsalya Research Laboratories Private Limited | ₹60 Lakh (FY 2025) | Gandhinagar, Gujarat, India | ||||
| Seventh Plane Life Sciences Private Limited | ₹59.6 Lakh (FY 2023) | -39.0% | New Delhi, Delhi, India | |||
| Advaita Life Sciences Private Limited | ₹58.93 Lakh (FY 2025) | -32.0% | Hyderabad, Telangana, India | |||
| Herbal Consultants Private Limited | ₹58.48 Lakh (FY 2022) | -52.0% | Mumbai, Maharashtra, India | |||
| Aarsh Pharmaceuticals and Research Private Limited | ₹58.32 Lakh (FY 2025) | -37.0% | Valsad, Gujarat, India | |||
| Avishkaran-Foundation for Pharma Innovationthis company | ₹56.83 Lakh (FY 2025) | -₹8.26 Lakh | -14.5% | -15.0% | Hyderabad, Telangana, India | |
| Ethicscare Clinical Research Services Private Limited | ₹56.48 Lakh (FY 2025) | -1.0% | Mohali, Punjab, India | |||
| Sure Health Labs & Lifesciences Private Limited | ₹56.35 Lakh (FY 2024) | Bhopal, Madhya Pradesh, India | ||||
| Gipson Health Care Private Limited | ₹55.15 Lakh (FY 2025) | 32.0% | Rajkot, Gujarat, India | |||
| International Drug Discovery & Clinical Research Private Limited | ₹54.36 Lakh (FY 2019) | -49.0% | Hyderabad, Telangana, India | |||
| Genelife Clinical Research Private Limited | ₹54.27 Lakh (FY 2024) | -47.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Avishkaran-Foundation for Pharma Innovation, buy the company report.
Legal cases
No court or tribunal cases involving Avishkaran-Foundation for Pharma Innovation are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Avishkaran-Foundation for Pharma Innovation; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Avishkaran-Foundation for Pharma Innovation has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAUCA8876B1Z5 | Telangana | Active | 22 Jun 2021 |
To see the full GST registrations and return filing status of Avishkaran-Foundation for Pharma Innovation, buy the company report.
Recent activity
Avishkaran-Foundation for Pharma Innovation has 14 board changes on record since 2021: 7 appointments and 7 cessations. The latest: Anand Govindaluri ceased to be Additional Director on 29 Sep 2024.
5 earlier events are in the company report.
Frequently asked questions
Avishkaran-Foundation for Pharma Innovation is an active private not for profit company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 03 March 2021 (5+ years old) and is registered under CIN U85300TG2021NPL149258.
Avishkaran-Foundation for Pharma Innovation has 7 current directors:
- Nanduri Srinivas - Director
- Gananadhamu Samanthula - Director
- Padmaja Surapureddy - Director
- Anil Wali - Director
- Ramjee Pallela - Director
- Saurabh Srivastava - Director
- Anand Govindaluri - Director
The latest financial statements of Avishkaran-Foundation for Pharma Innovation on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 19 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Avishkaran-Foundation for Pharma Innovation is 36AAUCA8876B1Z5, registered in Telangana.
The CIN (Corporate Identification Number) of Avishkaran-Foundation for Pharma Innovation is U85300TG2021NPL149258. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avishkaran-Foundation for Pharma Innovation was incorporated on 03 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Avishkaran-Foundation for Pharma Innovation by revenue are Vatsalya Research Laboratories Private Limited, Seventh Plane Life Sciences Private Limited, Advaita Life Sciences Private Limited, Herbal Consultants Private Limited, Aarsh Pharmaceuticals and Research Private Limited and 5 more, all in the Pharma industry (Contract Research).
Anand Govindaluri ceased to be Additional Director on 29 Sep 2024. Anil Wali ceased to be Additional Director on 29 Sep 2024. Padmaja Surapureddy ceased to be Additional Director on 29 Sep 2024. Avishkaran-Foundation for Pharma Innovation has 14 board changes on record in total.
The registered office of Avishkaran-Foundation for Pharma Innovation is at Niper Opp. Rai Business School Beside Idpl Balanagar Hyderabad, Telangana, India – 500037.
Avishkaran-Foundation for Pharma Innovation operates in the pharma industry, in the pharma contract r and d segment.
Avishkaran-Foundation for Pharma Innovation can be reached at its registered office: Niper Opp. Rai Business School Beside Idpl Balanagar Hyderabad, Telangana, India – 500037.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
